Feedback / Questions
HER2Bi-armed ATC - TransTarget, Barbara Ann Karmanos Cancer Institute
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT03406858
May 3, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next